Human Milk Oligosaccharides (HMOs) Post-market Study on Infants

NCT04055363 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

207

Enrollment

INDUSTRY

Sponsor class

Conditions

Growth
Tolerance
Adverse Event
Disorder of Intestine
Disorder Lung

Interventions

OTHER: HMO-supplemented infant formula

Sponsor

Société des Produits Nestlé (SPN)

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]